Share Price and Basic Stock Data
Last Updated: December 31, 2025, 7:28 pm
| PEG Ratio | -0.74 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Indo Rama Synthetics (India) Ltd operates in the textiles industry, specifically focusing on synthetic blended spinning. The company’s market capitalization is ₹1,265 Cr, with its stock currently priced at ₹48.3. The firm reported sales of ₹4,085 Cr for the financial year ending March 2023, which marked a slight increase over the ₹4,038 Cr reported in the previous year. However, the sales trend in the recent quarters has shown fluctuations, with quarterly sales recording ₹1,179 Cr in June 2022, dropping to ₹770 Cr by June 2023, before rebounding to ₹1,259 Cr in September 2023. This volatility in sales reflects challenges in the textile sector, likely influenced by raw material costs and demand dynamics. The trailing twelve-month sales stood at ₹4,890 Cr, indicating a potential recovery as the company approaches the end of FY 2025. The operating profit margin (OPM) has varied, recorded at 1% for March 2023, and expected to rise to 4.85% by March 2025, indicating an effort to stabilize profitability amidst market pressures.
Profitability and Efficiency Metrics
Indo Rama Synthetics has faced significant profitability challenges, with a reported net profit of ₹142 Cr for the fiscal year ending March 2023, a stark contrast to the previous year’s profit of ₹269 Cr. The company’s operating profit margin has fluctuated, particularly dropping to -3% in June 2023, before showing signs of recovery with a projected OPM of 4.85% for March 2025. The return on equity (ROE) stood at 0.66%, which is low compared to industry averages, suggesting inefficiencies in generating returns for shareholders. Additionally, the interest coverage ratio (ICR) was recorded at 1.32x, indicating that the company is just covering its interest obligations. The cash conversion cycle (CCC) is noteworthy at -63 days, reflecting efficient management of working capital, as the company can convert its investments in inventory and receivables back into cash quickly. However, the high reliance on borrowings, which stood at ₹1,087 Cr, poses a risk to sustaining profitability under adverse market conditions.
Balance Sheet Strength and Financial Ratios
The balance sheet of Indo Rama Synthetics exhibits a mixed scenario. The company reported total borrowings of ₹1,087 Cr against reserves of ₹184 Cr, indicating a high reliance on debt financing. This is further reflected in the debt-to-equity ratio, which stood at 3.06x, suggesting a significant leverage position compared to sector norms. The current ratio of 0.62x and quick ratio of 0.34x indicate liquidity challenges, as the company may struggle to meet short-term obligations without additional financing. However, fixed assets have increased to ₹1,264 Cr by March 2025, supporting the company’s operational capabilities. The return on capital employed (ROCE) improved to 20.27%, signaling better utilization of capital despite the high leverage. Overall, while the company’s asset base has grown, the heavy debt burden raises concerns over financial stability and the ability to fund future growth without incurring additional risks.
Shareholding Pattern and Investor Confidence
The shareholding structure of Indo Rama Synthetics reveals a strong promoter holding of 74.84%, which reflects a substantial commitment from the founding members. However, foreign institutional investors (FIIs) have a minimal presence at just 0.37%, indicating limited international confidence in the stock. Domestic institutional investors (DIIs) hold 0.92%, further emphasizing the cautious stance of institutional investors towards the company. The public shareholding stood at 23.86%, with a total of 26,651 shareholders as of September 2025. The gradual increase in public shareholding from 21.90% in December 2022 to 23.86% reflects growing retail interest, but the low institutional participation could signal concerns about the company’s growth prospects. The stability in promoter holding suggests confidence in the company’s long-term vision, which could be crucial in navigating future market challenges and attracting institutional investment.
Outlook, Risks, and Final Insight
Looking ahead, Indo Rama Synthetics faces both opportunities and challenges. The anticipated recovery in sales and operating margins indicates potential for improved financial performance. However, the reliance on high levels of debt poses a significant risk, particularly in a fluctuating market. The company must focus on enhancing operational efficiency and managing costs to sustain profitability. Additionally, the textile industry is subject to volatility due to raw material price fluctuations and changing consumer preferences, which could impact sales. The firm’s ability to innovate and adapt to market demands will be critical for long-term success. If Indo Rama can successfully navigate these challenges, it may strengthen its position in the industry, but failure to address its financial vulnerabilities could hinder growth and investor confidence. The balance between leveraging growth opportunities and managing risks will dictate the company’s future trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Threads (I) Ltd | 157 Cr. | 45.1 | 62.0/31.4 | 28.5 | 0.00 % | 2.90 % | 1.41 % | 10.0 | |
| Deepak Spinners Ltd | 87.2 Cr. | 121 | 203/116 | 311 | 0.00 % | 3.67 % | 4.31 % | 10.0 | |
| APM Industries Ltd | 92.9 Cr. | 43.0 | 54.9/31.0 | 118 | 78.6 | 0.00 % | 1.02 % | 0.32 % | 2.00 |
| Aditya Spinners Ltd | 31.5 Cr. | 18.8 | 33.5/16.5 | 27.3 | 0.00 % | 1.17 % | 3.82 % | 10.0 | |
| Adinath Textiles Ltd | 14.7 Cr. | 21.6 | 43.4/15.5 | 4.39 | 0.00 % | 3.75 % | 2.73 % | 10.0 | |
| Industry Average | 1,003.80 Cr | 108.97 | 47.14 | 130.19 | 0.13% | 4.20% | 2.96% | 8.20 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,137 | 890 | 880 | 770 | 1,259 | 940 | 904 | 944 | 951 | 1,166 | 1,198 | 1,306 | 1,221 |
| Expenses | 1,135 | 932 | 857 | 794 | 1,228 | 997 | 895 | 915 | 948 | 1,102 | 1,116 | 1,215 | 1,152 |
| Operating Profit | 2 | -42 | 23 | -24 | 31 | -56 | 10 | 29 | 3 | 63 | 82 | 91 | 68 |
| OPM % | 0% | -5% | 3% | -3% | 2% | -6% | 1% | 3% | 0% | 5% | 7% | 7% | 6% |
| Other Income | 19 | 0 | 5 | 1 | 1 | 4 | 1 | 1 | 3 | 2 | 23 | 3 | 2 |
| Interest | 12 | 16 | 20 | 24 | 31 | 37 | 41 | 38 | 38 | 40 | 42 | 29 | 34 |
| Depreciation | 8 | 8 | 8 | 8 | 10 | 10 | 11 | 12 | 12 | 13 | 12 | 12 | 12 |
| Profit before tax | 1 | -66 | 0 | -55 | -9 | -99 | -40 | -19 | -44 | 14 | 51 | 53 | 25 |
| Tax % | -16% | 0% | -1,373% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 1 | -66 | 2 | -55 | -9 | -99 | -40 | -19 | -44 | 14 | 51 | 53 | 25 |
| EPS in Rs | 0.04 | -2.52 | 0.06 | -2.11 | -0.34 | -3.79 | -1.55 | -0.73 | -1.69 | 0.52 | 1.96 | 2.02 | 0.94 |
Last Updated: January 1, 2026, 7:46 am
Below is a detailed analysis of the quarterly data for Indo Rama Synthetics (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,221.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,306.00 Cr. (Jun 2025) to 1,221.00 Cr., marking a decrease of 85.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,152.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,215.00 Cr. (Jun 2025) to 1,152.00 Cr., marking a decrease of 63.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 68.00 Cr.. The value appears to be declining and may need further review. It has decreased from 91.00 Cr. (Jun 2025) to 68.00 Cr., marking a decrease of 23.00 Cr..
- For OPM %, as of Sep 2025, the value is 6.00%. The value appears to be declining and may need further review. It has decreased from 7.00% (Jun 2025) to 6.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Jun 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 34.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Jun 2025) to 34.00 Cr., marking an increase of 5.00 Cr..
- For Depreciation, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 12.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Jun 2025) to 25.00 Cr., marking a decrease of 28.00 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Jun 2025) to 25.00 Cr., marking a decrease of 28.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.94. The value appears to be declining and may need further review. It has decreased from 2.02 (Jun 2025) to 0.94, marking a decrease of 1.08.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:12 am
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,908 | 2,656 | 2,758 | 2,525 | 2,459 | 2,106 | 2,043 | 4,038 | 4,085 | 3,873 | 4,259 | 4,890 |
| Expenses | 2,867 | 2,629 | 2,635 | 2,464 | 2,479 | 2,128 | 1,950 | 3,734 | 4,041 | 3,910 | 4,080 | 4,586 |
| Operating Profit | 41 | 27 | 122 | 61 | -20 | -22 | 93 | 304 | 44 | -37 | 179 | 305 |
| OPM % | 1% | 1% | 4% | 2% | -1% | -1% | 5% | 8% | 1% | -1% | 4% | 6% |
| Other Income | 202 | 136 | 5 | -24 | 55 | 20 | 10 | 9 | 22 | 4 | 28 | 30 |
| Interest | 45 | 50 | 43 | 54 | 91 | 92 | 66 | 62 | 60 | 132 | 157 | 144 |
| Depreciation | 158 | 143 | 117 | 78 | 79 | 86 | 34 | 31 | 31 | 39 | 48 | 49 |
| Profit before tax | 40 | -31 | -33 | -94 | -135 | -180 | 3 | 219 | -25 | -203 | 1 | 142 |
| Tax % | -1% | -56% | -38% | -140% | -40% | 75% | -3,245% | -23% | -1% | 0% | 0% | |
| Net Profit | 40 | -14 | -21 | 38 | -81 | -317 | 113 | 269 | -25 | -203 | 1 | 142 |
| EPS in Rs | 2.65 | -0.89 | -1.36 | 2.48 | -5.36 | -12.12 | 4.34 | 10.30 | -0.94 | -7.79 | 0.05 | 5.44 |
| Dividend Payout % | 38% | -112% | -73% | 40% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -135.00% | -50.00% | 280.95% | -313.16% | 135.65% | 138.05% | -109.29% | -712.00% | 100.49% |
| Change in YoY Net Profit Growth (%) | 0.00% | 85.00% | 330.95% | -594.11% | 448.80% | 2.41% | -247.35% | -602.71% | 812.49% |
Indo Rama Synthetics (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2013-2014 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 15% |
| 3 Years: | 2% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 15% |
| 3 Years: | -79% |
| TTM: | 144% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 23% |
| 3 Years: | -5% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | -15% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 7:25 am
Balance Sheet
Last Updated: December 4, 2025, 1:25 am
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 152 | 152 | 152 | 152 | 152 | 261 | 261 | 261 | 261 | 261 | 261 | 261 |
| Reserves | 476 | 436 | 397 | 450 | 350 | -39 | 72 | 339 | 312 | 107 | 107 | 184 |
| Borrowings | 713 | 658 | 517 | 321 | 307 | 471 | 395 | 354 | 890 | 1,339 | 1,136 | 1,087 |
| Other Liabilities | 846 | 823 | 820 | 1,006 | 799 | 790 | 983 | 1,152 | 1,250 | 1,199 | 1,431 | 1,439 |
| Total Liabilities | 2,187 | 2,069 | 1,886 | 1,929 | 1,608 | 1,483 | 1,711 | 2,105 | 2,713 | 2,907 | 2,936 | 2,971 |
| Fixed Assets | 1,176 | 1,270 | 1,134 | 935 | 898 | 703 | 691 | 702 | 783 | 1,217 | 1,264 | 1,247 |
| CWIP | 206 | 3 | 6 | 16 | 11 | 7 | 9 | 35 | 324 | 105 | 36 | 38 |
| Investments | 10 | 4 | 16 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 795 | 791 | 730 | 977 | 698 | 773 | 1,012 | 1,368 | 1,605 | 1,584 | 1,636 | 1,685 |
| Total Assets | 2,187 | 2,069 | 1,886 | 1,929 | 1,608 | 1,483 | 1,711 | 2,105 | 2,713 | 2,907 | 2,936 | 2,971 |
Below is a detailed analysis of the balance sheet data for Indo Rama Synthetics (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 261.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 261.00 Cr..
- For Reserves, as of Sep 2025, the value is 184.00 Cr.. The value appears strong and on an upward trend. It has increased from 107.00 Cr. (Mar 2025) to 184.00 Cr., marking an increase of 77.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,087.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 1,136.00 Cr. (Mar 2025) to 1,087.00 Cr., marking a decrease of 49.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,439.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,431.00 Cr. (Mar 2025) to 1,439.00 Cr., marking an increase of 8.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,971.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,936.00 Cr. (Mar 2025) to 2,971.00 Cr., marking an increase of 35.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,247.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,264.00 Cr. (Mar 2025) to 1,247.00 Cr., marking a decrease of 17.00 Cr..
- For CWIP, as of Sep 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2025) to 38.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,685.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,636.00 Cr. (Mar 2025) to 1,685.00 Cr., marking an increase of 49.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,971.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,936.00 Cr. (Mar 2025) to 2,971.00 Cr., marking an increase of 35.00 Cr..
However, the Borrowings (1,087.00 Cr.) are higher than the Reserves (184.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -672.00 | -631.00 | -395.00 | -260.00 | -327.00 | -493.00 | -302.00 | -50.00 | -846.00 | -38.00 | 178.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 16 | 16 | 29 | 20 | 16 | 19 | 17 | 14 | 16 | 14 |
| Inventory Days | 46 | 48 | 46 | 48 | 36 | 57 | 102 | 67 | 73 | 67 | 65 |
| Days Payable | 80 | 87 | 92 | 136 | 132 | 126 | 221 | 126 | 125 | 120 | 142 |
| Cash Conversion Cycle | -24 | -23 | -30 | -60 | -76 | -53 | -100 | -43 | -38 | -38 | -63 |
| Working Capital Days | -50 | -42 | -43 | -50 | -69 | -52 | -62 | -22 | -25 | -81 | -73 |
| ROCE % | -8% | 1% | -1% | -8% | 11% | 33% | 3% | -4% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.05 | -7.79 | -0.94 | 10.30 | 4.34 |
| Diluted EPS (Rs.) | 0.05 | -7.79 | -0.94 | 10.30 | 4.34 |
| Cash EPS (Rs.) | 1.90 | -6.29 | 0.25 | 11.50 | 5.63 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.10 | 14.10 | 21.93 | 22.99 | 12.76 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.10 | 14.10 | 21.93 | 22.99 | 12.76 |
| Revenue From Operations / Share (Rs.) | 163.11 | 148.34 | 156.44 | 154.65 | 78.24 |
| PBDIT / Share (Rs.) | 7.92 | -1.25 | 2.54 | 11.97 | 4.39 |
| PBIT / Share (Rs.) | 6.08 | -2.75 | 1.34 | 10.77 | 3.10 |
| PBT / Share (Rs.) | 0.05 | -7.79 | -0.94 | 8.40 | 0.12 |
| Net Profit / Share (Rs.) | 0.05 | -7.79 | -0.94 | 10.30 | 4.34 |
| NP After MI And SOA / Share (Rs.) | 0.05 | -7.79 | -0.94 | 10.30 | 4.34 |
| PBDIT Margin (%) | 4.85 | -0.84 | 1.62 | 7.74 | 5.61 |
| PBIT Margin (%) | 3.72 | -1.85 | 0.85 | 6.96 | 3.96 |
| PBT Margin (%) | 0.03 | -5.25 | -0.60 | 5.43 | 0.16 |
| Net Profit Margin (%) | 0.03 | -5.25 | -0.60 | 6.66 | 5.54 |
| NP After MI And SOA Margin (%) | 0.03 | -5.25 | -0.60 | 6.66 | 5.54 |
| Return on Networth / Equity (%) | 0.38 | -55.26 | -4.28 | 44.82 | 34.02 |
| Return on Capital Employeed (%) | 20.27 | -8.97 | 2.91 | 33.63 | 13.26 |
| Return On Assets (%) | 0.04 | -6.99 | -0.90 | 12.77 | 6.62 |
| Long Term Debt / Equity (X) | 0.97 | 0.99 | 0.97 | 0.28 | 0.69 |
| Total Debt / Equity (X) | 3.06 | 3.58 | 1.51 | 0.53 | 0.91 |
| Asset Turnover Ratio (%) | 1.46 | 1.38 | 1.70 | 2.07 | 1.27 |
| Current Ratio (X) | 0.62 | 0.60 | 0.85 | 0.81 | 0.69 |
| Quick Ratio (X) | 0.34 | 0.32 | 0.43 | 0.39 | 0.32 |
| Inventory Turnover Ratio (X) | 7.19 | 4.62 | 5.12 | 6.16 | 4.49 |
| Interest Coverage Ratio (X) | 1.32 | -0.24 | 1.11 | 5.05 | 1.74 |
| Interest Coverage Ratio (Post Tax) (X) | 1.01 | -0.54 | 0.58 | 5.35 | 2.90 |
| Enterprise Value (Cr.) | 1984.69 | 2303.81 | 1824.56 | 2023.51 | 1310.44 |
| EV / Net Operating Revenue (X) | 0.46 | 0.59 | 0.44 | 0.50 | 0.64 |
| EV / EBITDA (X) | 9.60 | -70.43 | 27.56 | 6.47 | 11.42 |
| MarketCap / Net Operating Revenue (X) | 0.20 | 0.26 | 0.24 | 0.42 | 0.49 |
| Price / BV (X) | 2.41 | 2.76 | 1.78 | 2.86 | 3.05 |
| Price / Net Operating Revenue (X) | 0.20 | 0.26 | 0.24 | 0.42 | 0.49 |
| EarningsYield | 0.00 | -0.20 | -0.02 | 0.15 | 0.11 |
After reviewing the key financial ratios for Indo Rama Synthetics (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from -7.79 (Mar 24) to 0.05, marking an increase of 7.84.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from -7.79 (Mar 24) to 0.05, marking an increase of 7.84.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.90. This value is below the healthy minimum of 3. It has increased from -6.29 (Mar 24) to 1.90, marking an increase of 8.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.10. There is no change compared to the previous period (Mar 24) which recorded 14.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.10. There is no change compared to the previous period (Mar 24) which recorded 14.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 163.11. It has increased from 148.34 (Mar 24) to 163.11, marking an increase of 14.77.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 7.92. This value is within the healthy range. It has increased from -1.25 (Mar 24) to 7.92, marking an increase of 9.17.
- For PBIT / Share (Rs.), as of Mar 25, the value is 6.08. This value is within the healthy range. It has increased from -2.75 (Mar 24) to 6.08, marking an increase of 8.83.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.05. This value is within the healthy range. It has increased from -7.79 (Mar 24) to 0.05, marking an increase of 7.84.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 2. It has increased from -7.79 (Mar 24) to 0.05, marking an increase of 7.84.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 2. It has increased from -7.79 (Mar 24) to 0.05, marking an increase of 7.84.
- For PBDIT Margin (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 10. It has increased from -0.84 (Mar 24) to 4.85, marking an increase of 5.69.
- For PBIT Margin (%), as of Mar 25, the value is 3.72. This value is below the healthy minimum of 10. It has increased from -1.85 (Mar 24) to 3.72, marking an increase of 5.57.
- For PBT Margin (%), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 10. It has increased from -5.25 (Mar 24) to 0.03, marking an increase of 5.28.
- For Net Profit Margin (%), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from -5.25 (Mar 24) to 0.03, marking an increase of 5.28.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 8. It has increased from -5.25 (Mar 24) to 0.03, marking an increase of 5.28.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 15. It has increased from -55.26 (Mar 24) to 0.38, marking an increase of 55.64.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.27. This value is within the healthy range. It has increased from -8.97 (Mar 24) to 20.27, marking an increase of 29.24.
- For Return On Assets (%), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from -6.99 (Mar 24) to 0.04, marking an increase of 7.03.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.97. This value is within the healthy range. It has decreased from 0.99 (Mar 24) to 0.97, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.06. This value exceeds the healthy maximum of 1. It has decreased from 3.58 (Mar 24) to 3.06, marking a decrease of 0.52.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.46. It has increased from 1.38 (Mar 24) to 1.46, marking an increase of 0.08.
- For Current Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1.5. It has increased from 0.60 (Mar 24) to 0.62, marking an increase of 0.02.
- For Quick Ratio (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has increased from 0.32 (Mar 24) to 0.34, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.19. This value is within the healthy range. It has increased from 4.62 (Mar 24) to 7.19, marking an increase of 2.57.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 3. It has increased from -0.24 (Mar 24) to 1.32, marking an increase of 1.56.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 3. It has increased from -0.54 (Mar 24) to 1.01, marking an increase of 1.55.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,984.69. It has decreased from 2,303.81 (Mar 24) to 1,984.69, marking a decrease of 319.12.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has decreased from 0.59 (Mar 24) to 0.46, marking a decrease of 0.13.
- For EV / EBITDA (X), as of Mar 25, the value is 9.60. This value is within the healthy range. It has increased from -70.43 (Mar 24) to 9.60, marking an increase of 80.03.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 1. It has decreased from 0.26 (Mar 24) to 0.20, marking a decrease of 0.06.
- For Price / BV (X), as of Mar 25, the value is 2.41. This value is within the healthy range. It has decreased from 2.76 (Mar 24) to 2.41, marking a decrease of 0.35.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 1. It has decreased from 0.26 (Mar 24) to 0.20, marking a decrease of 0.06.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.20 (Mar 24) to 0.00, marking an increase of 0.20.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Indo Rama Synthetics (India) Ltd:
- Net Profit Margin: 0.03%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.27% (Industry Average ROCE: 4.2%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.38% (Industry Average ROE: 2.96%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.01
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.34
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 8.92 (Industry average Stock P/E: 47.14)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.03%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Spinning - Synthetic Blended | A-31, MIDC Industrial Area, Nagpur Maharashtra 441122 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Om Prakash Lohia | Chairman & Managing Director |
| Mr. Vishal Lohia | Whole Time Director |
| Mr. Sanjay Thapliyal | Whole Time Director |
| Mr. Dilip Kumar Agarwal | Non Exe.Non Ind.Director |
| Ms. Ranjana Agarwal | Ind. Non-Executive Woman Director |
| Mr. Dhanendra Kumar | Ind. Non-Executive Director |
| Mr. Dharmpal Agarwal | Ind. Non-Executive Director |
| Mr. Ravi Capoor | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Indo Rama Synthetics (India) Ltd?
Indo Rama Synthetics (India) Ltd's intrinsic value (as of 31 December 2025) is ₹0.82 which is 98.31% lower the current market price of ₹48.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,266 Cr. market cap, FY2025-2026 high/low of ₹75.0/29.1, reserves of ₹184 Cr, and liabilities of ₹2,971 Cr.
What is the Market Cap of Indo Rama Synthetics (India) Ltd?
The Market Cap of Indo Rama Synthetics (India) Ltd is 1,266 Cr..
What is the current Stock Price of Indo Rama Synthetics (India) Ltd as on 31 December 2025?
The current stock price of Indo Rama Synthetics (India) Ltd as on 31 December 2025 is ₹48.6.
What is the High / Low of Indo Rama Synthetics (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Indo Rama Synthetics (India) Ltd stocks is ₹75.0/29.1.
What is the Stock P/E of Indo Rama Synthetics (India) Ltd?
The Stock P/E of Indo Rama Synthetics (India) Ltd is 8.92.
What is the Book Value of Indo Rama Synthetics (India) Ltd?
The Book Value of Indo Rama Synthetics (India) Ltd is 17.1.
What is the Dividend Yield of Indo Rama Synthetics (India) Ltd?
The Dividend Yield of Indo Rama Synthetics (India) Ltd is 0.00 %.
What is the ROCE of Indo Rama Synthetics (India) Ltd?
The ROCE of Indo Rama Synthetics (India) Ltd is 9.94 %.
What is the ROE of Indo Rama Synthetics (India) Ltd?
The ROE of Indo Rama Synthetics (India) Ltd is 0.66 %.
What is the Face Value of Indo Rama Synthetics (India) Ltd?
The Face Value of Indo Rama Synthetics (India) Ltd is 10.0.